Starting Monday some Saskatchewan residents may notice a difference on their prescription drug bills.
That’s when the province’s price-setting initiative kicks in for six of the most widely used generic drugs, representing about 20 per cent of publicly funded spending of generic drugs in Canada.
Get weekly health news
Receive the latest medical news and health information delivered to you every Sunday.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.
The following six drugs will be priced at 18 per cent of the equivalent brand name drug:
- Atorvastatin, used to treat high cholesterol
- Ramipill, used to treat blood pressure
- Venlafaxine, used to treat depression and other mental health conditions.
- Amlodipine, used to treat high blood pressure
- Omeprazole, used to treat gastrointestinal conditions
- Rabeprazole, used to treat gastrointestinal conditions
The program is expected to save Saskatchewan residents about $10 million annually.
Comments
Want to discuss? Please read our Commenting Policy first.